Cove Private Wealth, LLC

Position in ABBV — AbbVie Inc.

CIK 2015131 Oyster Bay Cove, NY

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$3,107,754

+$455,464 QoQ

Shares Held

12,350

+1.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#1,633

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cove Private Wealth, LLC holds $15,609,330 across 10 Drug Manufacturers - General names. ABBV ranks #2 (19.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	17,139	$4,352,791
2	ABBV	AbbVie Inc. This page	12,350	$3,107,754
3	PFE	Pfizer Inc	84,332	$2,030,714
4	GILD	Gilead Sciences, Inc.	14,803	$1,870,211
5	MRK	Merck & Co., Inc.	9,510	$1,222,035
6	LLY	ELI LILLY & Co	925	$1,109,472
7	BMY	Bristol Myers Squibb Co	11,575	$666,951
8	NVS	Novartis AG	2,867	$449,316

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,107,754	12,350	+1.3%	Shares	Sole	2026-07-31
2026-03-31	$2,652,290	12,195	+9.6%	Shares	Sole	2026-05-14
2025-12-31	$2,543,322	11,131	+12.3%	Shares	Sole	2026-01-23
2025-09-30	$2,294,792	9,911	0.0%	Shares	Sole	2025-11-06
2025-06-30	$1,839,679	9,911	+171.0%	Shares	Sole	2025-07-16
2025-03-31	$766,214	3,657	+27.3%	Shares	Sole	2025-05-12
2024-12-31	$510,532	2,873	+4.5%	Shares	Sole	2025-01-16
2024-09-30	$543,070	2,750	0.0%	Shares	Sole	2024-10-25
2024-06-30	$471,680	2,750	0.0%	Shares	Sole	2024-07-24
2024-03-31	$500,775	2,750	0.0%	Shares	Sole	2024-05-01
2023-12-31	$426,167	2,750	—	Shares	Sole	2024-03-12
No filing history on record for this holder in this stock.